TIGIT and neoplasm: Within tumour CD4+ Treg cells, IgG2b and IgG2a anti-TIGIT antibodies reduced the expression of genes associated with suppressive capacity, including Tigit, Ccr8 and Ctla4 (Extended Data Fig. 5e).